Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivastigmine for Delirium in Intensive Care Patients, a Double-blind, Randomized Placebo-controlled add-on Trial

NCT00704301 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT00704301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00704301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivastigmine for Delirium in Intensive Care Patients, a Double-blind, Randomized Placebo-controlled add-on Trial
Lead sponsor
UMC Utrecht
Phase
Phase 4
Overall status
Terminated
Start date
November 30, 2008
Completion date
May 31, 2010
Enrollment
104 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

delirium